Alkaline phosphatase isoenzyme analysis in umbilical cord blood of healthy term neonates

S. Hemavathi; V. Sathiyapriya; C. Rekha; A. T. Arasar Seeralar; Pragna B. Dolia; Abinaya P.

doi:10.18203/2349-3291.ijcp20242020

Authors

S. Hemavathi Department of Pediatrics, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India
V. Sathiyapriya Department of Biochemistry, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India
C. Rekha Department of Pediatrics, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India
A. T. Arasar Seeralar Department of Pediatrics, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India
Pragna B. Dolia Department of Biochemistry, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India
Abinaya P. Department of Central Research Laboratory, ACS Medical College and Hospital, Velappanchavadi, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20242020

Keywords:

Cord blood alkaline phosphatase, Hyperbilirubinemia, Isoenzymes, Neonates, Prediction

Abstract

Background: Alkaline phosphatases are isoenzymes that hydrolyze the organic phosphate in the extracellular space to free phosphates; mostly they are present on the outer layer of the cell membrane similar to that on hepatocytes. The human body contains four isoenzymes: they are hepatic/bone/renal alkaline phosphatase (L/B/K ALP), intestinal alkaline phosphatase (IALP), placental alkaline phosphatase (PLALP isoenzyme), and germ cell alkaline phosphatase (GCALP). In clinical practice, alkaline phosphatase (ALP) is routinely measured as a marker of bone and hepatic function. In the field of neonatology, it is used in diagnosing and indicating the severity of metabolic bone disease (MBD) in preterm newborns. It is also used as an early predictor of neonatal jaundice. The current study is aimed at detecting the specific isoenzyme form of alkaline phosphatase elevated in the umbilical cord of newborns and its association with hyperbilirubinemia.

Methods: The study included 30-term newborns in a tertiary care hospital in Velappanchavadi, Chennai. After birth, cord blood was collected for the determination of alkaline phosphatase isoenzyme in the serum. The average alkaline phosphatase activity in the cord blood serum was 109±35 IU/l. The average percentage of alkaline phosphatase activity after treatment with heat, phenylalanine, and urea were 6, 11.5, and 87% respectively.

Results: It was evident that the isoenzyme form present in the umbilical cord of term healthy neonates is of intestinal origin.

Conclusions: The elevated intestinal form of alkaline phosphatase indicates an immature liver and thereby predicts the future development of hyperbilirubinemia.

Metrics

Metrics Loading ...

References

Green MR, Sambrook J. Alkaline Phosphatase. Cold Spring Harb Protoc. 2020;2020(8):100768.

Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020;754:144855.

Dixon IMC. Tissue non-specific alkaline phosphatase (TNAP): A player in post-MI cardiac fibrosis. EBioMedicine. 2021;68:103430.

Komoda T, Sakagishi Y. The function of the carbohydrate moiety and alteration of carbohydrate composition in human alkaline phosphatase isoenzymes. Biochim Biophys Acta. 1978;523(2):395-406.

Tsai LC, Hung MW, Chen YH, Su WC, Chang GG, Chang TC. Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells. Eur J Biochem. 2000;267(5):1330-9.

Millan JL, Manes R. Seminoma-derived nagao isozyme is encoded by a germ cell alkaline phosphatase gene. Proc Natl Acad Sci. 1988;85(9):3024-8.

Hofmann MC, Jeltsch W, Brecher J, Walt H. Alkaline phosphatase isozymes in human testicular germ cell tumors, precancerous stage, and three related cell lines. Cancer Res. 1989;49(17):4696-700.

Tinnion RJ, Embleton ND. How to use alkaline phosphatase in neonatology. Arch Dis Child Educ Pract Ed. 2012;97(4):157-63.

Nalbantoglu A, Ovali F, Nalbantoglu B. Alkaline phosphatase as an early marker of hemolysis in newborns. Pediatr Int. 2011;53(6):936-8.

Rostami N, Mehrabi Y. Identifying the newborn at risk for developing significant hyperbilirubinemia by measuring cord bilirubin levels. J Arab Neonatal Forum 2005;2:81-5.

Gale R, Seidman DS, Stevenson DK. Hyperbilirubinemia and early discharge. J Perinatol. 2001;21(1):40-3.

Mitra S, Rennie J. Neonatal jaundice: etiology, diagnosis, and treatment. Br J Hosp Med (Lond). 2017;78(12):699-704.

Ahmadpour-Kacho M, Pasha YZ, Haghshenas M, Rad ZA, Firouzjahi A, Bijani A, et al. Cord blood alkaline phosphatase as an indicator of neonatal jaundice. Iran J Pediatr. 2015;25(5):1-5.

El-Amin DM, Ahmed YA, Hashim AM, Asmail AH. Evaluation of cord blood alkaline phosphatase levels as an indicator of neonatal jaundice. Al-Azhar Assiut Medi J. 2020;18(2):112-7.

Elmonem H, El-DinA, Kholeef E, Eldin S. Alkaline phosphatase and haptoglobin as predictor of neonatal jaundice. Egypt J Hosp Medi. 2019;74(5):978-87.

Harris H. The human alkaline phosphatases: what we know and what we don’t know. Clin Chim Acta. 1990;186(2):133-50.

Bergström K, Lefvert AK. Practical aspects on the determination of serum alkaline phosphatase isoenzymes using l-phenylalanine and urea. Clinica Chimica Acta. 1975;64(1):95-100.

Verpooten GF, Hoylaerts MF, Nouwen EJ, et al. Human fetal intestinal alkaline phosphatase: molecular heterogeneity and immunological detection in amniotic fluids. Clin Chim Acra 1990;186(2):225-37.

Fishman WH, Inglis NI, Krant MJ. Serum alkaline phosphatase ofintestinal origin in patients with cancer and with cirrhosis of the liver. Chin Chim Acta 1965;12(3):298-303.

Moss DW. Perspectives in alkaline phosphatase research. Clin Chem. 1992;38(12):2486-92.